What is Thanatophoric Dysplasia

Thanatophoric dysplasia is a severe, life-limiting skeletal disorder characterized by extreme shortening of the limbs, a narrow chest, and an enlarged head. It is a rare genetic condition caused by mutations in the FGFR3 gene that disrupt normal bone growth and development, typically leading to respiratory failure shortly after birth.

What are the primary characteristics of Thanatophoric Dysplasia?

Thanatophoric dysplasia affects the entire skeletal system, preventing bones from growing to their typical size. The primary clinical features include disproportionately short arms and legs, a small, bell-shaped rib cage that limits lung development, and macrocephaly (an enlarged head) with a prominent forehead. Because the chest cavity is too small to support adequate breathing, most infants with thanatophoric dysplasia experience severe respiratory insufficiency.

What are the subtypes of Thanatophoric Dysplasia?

Medical professionals classify thanatophoric dysplasia into two distinct types based on physical presentation:

• Type I: Characterized by short, curved femurs (thigh bones) and a relatively flat vertebral column (platyspondyly).


• Type II: Distinguished by straight, short femurs and a hallmark cloverleaf-shaped skull (kleeblattschädel) caused by premature fusion of the skull bones.

How common is Thanatophoric Dysplasia and who is affected?

Thanatophoric dysplasia is an extremely rare condition with an estimated prevalence of 1 in 20,000 to 1 in 50,000 births. It affects both males and females equally across all ethnic and geographic populations. While 36 people have shared their experiences regarding thanatophoric dysplasia on DiseaseMaps.org, the condition is typically diagnosed prenatally via ultrasound or immediately at birth.

How does the genetics of Thanatophoric Dysplasia work?

Thanatophoric dysplasia is caused by a sporadic "de novo" mutation in the FGFR3 gene. This means it is almost never inherited from a parent; instead, the mutation occurs randomly in the egg or sperm cell at the time of conception. The mutation causes the FGFR3 protein to remain "turned on," which severely inhibits the growth of chondrocytes (cartilage cells) in the growth plates of bones.

Next steps

• Consult with a clinical geneticist to discuss genetic testing and recurrence risks for future pregnancies.


• Connect with the 36 community members on DiseaseMaps.org to share experiences and find support.


• Seek guidance from a perinatal palliative care team to discuss compassionate care options for your infant.


• Reach out to organizations like the Little People of America (LPA) for specialized resources.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Thanatophoric Dysplasia


• Orphanet: Thanatophoric Dysplasia (ORPHA:2378)


• OMIM (Online Mendelian Inheritance in Man): #187600 (Type I) and #187601 (Type II)